Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-009188

Chief Financial Officer sold 1,000 shares at $230.36 ($230,360)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sandercock Brett · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-10 Sale : show line 1 in the form 10b5-1 −1,000 $230.36 $230,360 90,864 D
Open-market sales · 1,000 sh · avg $230.36 · $230,360
Loading xslF345X05/form4.xml…